Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine premedication before ketamine for electroconvulsive therapy hemodynamic response
IRCT20160307026950N10Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine and ketamine in mental disorder (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Blood pressure and Heart rate. Started Mar 2018; status: completed.
02
Drugs
dexmedetomidineketamine
03
Conditions
mental disorder
Beyond the preview
Go deeper on IRCT20160307026950N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N10.